title: Parenteral lorazepam's unavailability in Australia and the impact for catatonic patients.
authors.affiliation: 1 School of Medicine, University of Adelaide, Adelaide, SA, Australia.
authors.forename: David Alvin
authors.initials: DA
authors.lastname: Low
authors.affiliation: 1 School of Medicine, University of Adelaide, Adelaide, SA, Australia.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Xu
authors.affiliation: 2 The Queen Elizabeth Hospital, Woodville South, SA, Australia.
authors.forename: Prashant
authors.initials: P
authors.lastname: Tibrewal
authors.affiliation: 2 The Queen Elizabeth Hospital, Woodville South, SA, Australia.|3 Discipline of Psychiatry, Flinders University, Adelaide, SA, Australia.
authors.forename: Tarun
authors.initials: T
authors.lastname: Bastiampillai
authors.affiliation: 2 The Queen Elizabeth Hospital, Woodville South, SA, Australia.
authors.forename: Rohan
authors.initials: R
authors.lastname: Dhillon
mesh_terms: D000368:Aged; D002389:Catatonia / Q000188:drug therapy / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D007263:Infusions, Parenteral; D008140:Lorazepam / Q000008:administration & dosage* / Q000494:pharmacology / Q000600:supply & distribution*; D008297:Male
chemical_list: D008140:Lorazepam